The "all of us" research program

New England Journal of Medicine

Volumn 381, Issue 7, 2019, Pages 668-676

  Denny, Joshua C ^a   Rutter, Joni L ^b   Goldstein, David B ^c,d   Philippakis, Anthony ^e   Smoller, Jordan W ^e,f   Jenkins, Gwynne ^a   Dishman, Eric ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BODY MASS; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DIGITAL LITERACY; ELECTRONIC HEALTH RECORD; FUNDING; GENETIC COUNSELING; GENOTYPE; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; LONGITUDINAL STUDY; MACHINE LEARNING; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; TAXONOMY; WHOLE GENOME SEQUENCING; BIOBANK; HEALTH SURVEY; INFORMATION PROCESSING; METHODOLOGY; OBSERVATIONAL STUDY; UNITED STATES;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; COHORT STUDIES; DATASETS AS TOPIC; ELECTRONIC HEALTH RECORDS; HEALTH SURVEYS; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; PRECISION MEDICINE; RESEARCH DESIGN; UNITED STATES;

EID: 85070840174     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsr1809937     Document Type: Article

References (42)

1. Popejoy AB, Fullerton SM. Genomics is failing on diversity. Nature 2016; 538: 161-4.
2. Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data 2016; 3: 160018.
3. Manrai AK, Funke BH, Rehm HL, et al. Genetic misdiagnoses and the potential for health disparities. N Engl J Med 2016; 375: 655-65.
4. Collins FS, Tabak LA. Policy: NIH plans to enhance reproducibility. Nature 2014; 505: 612-3.
5. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015; 372: 793-5.
6. Agency for Healthcare Research and Quality. 2016 National healthcare quality and disparities report (https://www.ahrq.gov/research/ findings/ nhqrdr/ nhqdr16/ index .html).
7. The Precision Medicine Initiative Cohort Program-building a research foundation for 21st century medicine: Precision Medicine Initiative (PMI) working group report to the advisory committee to the director, NIH. Bethesda, MD: National Institutes of Health, 2015 (http://www.nih.gov/precisionmedicine/ 09172015-pmi-working-group-report .pdf).
8. Kaufman DJ, Baker R, Milner LC, Devaney S, Hudson KL. A survey of U.S adults' opinions about conduct of a nationwide Precision Medicine Initiative cohort study of genes and environment. PLoS One 2016; 11(8): e0160461.
9. Wilkins CH. Precision medicine for everyone. NEJM Catalyst. February 12, 2018 (https://catalyst .nejm .org/ precision-medicine-initiative-everyone/ ).
10. Cronin RM, Jerome RN, Mapes B, et al. Development of the initial surveys for the All of Us Research Program. Epidemiology 2019; 30: 597-608.
11. National Institutes of Health. The All of Us Research Program initial protocol. August 4, 2017 (https://allofus .nih.gov/news-events-and-media/ announcements/ all-us-research-program-initial-protocol).
12. Demographics Research Group. The racial dot map. Charlottesville, VA: Weldon Cooper Center for Public Service, July 2013 (https://demographics .coopercenter .org/ racial-dot-map/ ).
13. Hripcsak G, Ryan PB, Duke JD, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A 2016; 113: 7329-36.
14. Sudlow C, Gallacher J, Allen N, et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 2015; 12(3): e1001779.
15. Workbench-All of Us research hub (https://www.researchallofus .org/ data/ workbench/ ).
16. National Institutes of Health. Genomics Working Group of the All of Us Research Program Advisory Panel (https://allofus .nih.gov/genomics-working-group-all-us-research-program-advisory-panel).
17. Relling MV, Klein TE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther 2011; 89: 464-7.
18. Kalia SS, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 2017; 19: 249-55.
19. Dewey FE, Murray MF, Overton JD, et al. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study. Science 2016; 354: aaf6814-1-10.
20. Van Driest SL, Shi Y, Bowton EA, et al. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther 2014; 95: 423-31.
21. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J III. Factors of risk in the development of coronary heart disease-six year follow-up experience: the Framingham Study. Ann Intern Med 1961; 55: 33-50.
22. Rosenquist JN, Lehrer SF, O'Malley AJ, Zaslavsky AM, Smoller JW, Christakis NA. Cohort of birth modifies the association between FTO genotype and BMI. Proc Natl Acad Sci U S A 2015; 112: 354-9.
23. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146: 483-94.
24. Hudson KL, Collins FS. The 21st Century Cures Act-a view from the NIH. N Engl J Med 2017; 376: 111-3.
25. H.R. 34, 114th Cong.: 21st Century Cures Act (2015-2016). Congress.gov (https://www.congress.gov/bill/ 114th-congress/ house-bill/ 34).
26. Gaziano JM, Concato J, Brophy M, et al. Million Veteran Program: a mega-biobank to study genetic influences on health and disease. J Clin Epidemiol 2016; 70: 214-23.
27. Chen Z, Chen J, Collins R, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol 2011; 40: 1652-66.
28. Gottesman O, Kuivaniemi H, Tromp G, et al. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med 2013; 15: 761-71.
29. Rajkomar A, Oren E, Chen K, et al. Scalable and accurate deep learning with electronic health records. NPJ Digital Med 2018; 1(1): 18.
30. Miotto R, Li L, Kidd BA, Dudley JT. Deep patient: an unsupervised representation to predict the future of patients from the electronic health records. Sci Rep 2016; 6: 26094.
31. Crawford DC, Crosslin DR, Tromp G, et al. eMERGEing progress in genomics-the first seven years. Front Genet 2014; 5: 184.
32. Galea S, Abdalla SM. Precision medicine approaches and the health of populations: study design concerns and considerations. Perspect Biol Med 2018; 61: 527-36.
33. Joyner MJ, Paneth N. Seven questions for personalized medicine. JAMA 2015; 314: 999-1000.
34. Khoury MJ, Evans JP. A public health perspective on a national precision medicine cohort: balancing long-term knowledge generation with early health benefit. JAMA 2015; 313: 2117-8.
35. Psaty BM, Dekkers OM, Cooper RS. Comparison of 2 treatment models: precision medicine and preventive medicine. JAMA 2018; 320: 751-2.
36. Wei W-Q, Leibson CL, Ransom JE, et al. Impact of data fragmentation across healthcare centers on the accuracy of a highthroughput clinical phenotyping algorithm for specifying subjects with type 2 diabetes mellitus. J Am Med Inform Assoc 2012; 19: 219-24.
37. Kho AN, Pacheco JA, Peissig PL, et al. Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med 2011; 3: 79re1.
38. Denny JC, Bastarache L, Ritchie MD, et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol 2013; 31: 1102-10.
39. Giri A, Hellwege JN, Keaton JM, et al. Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat Genet 2019; 51: 51-62.
40. Khoury MJ, Galea S. Will precision medicine improve population health? JAMA 2016; 316: 1357-8.
41. Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA 2017; 318: 1925-6.
42. Khera AV, Emdin CA, Drake I, et al. Genetic risk, adherence to a healthy lifestyle, and coronary disease. N Engl J Med 2016; 375: 2349-58.